Diversified Consumer Services
Company Overview of University of California-Los Angeles
University of California-Los Angeles is an educational institution offering undergraduate and graduate programs such as arts and architecture, dentistry, education and information studies, law, management, medicine, nursing, and public health. The schools of the university include The College of Letters and Science, offering programs such as social sciences, humanities, life sciences, physical sciences, and honors; The Henry Samueli School of Engineering and Applied Science; School of the Arts and Architecture; School of Theater, Film and Television; School of Nursing; and School of Public Policy and Social Research. University of California - Los Angeles was founded in 1919 and is based in ...
405 Hilgard Avenue
Los Angeles, CA 90095-1361
Founded in 1919
Key Executives for University of California-Los Angeles
Professor in the Department of Molecular and Medical Pharmacology
Executive Vice Chancellor and Provost
Executive Director of the Wireless Health Institute
Compensation as of Fiscal Year 2015.
University of California-Los Angeles Key Developments
University of California-Los Angeles Presents at Alliance for Regenerative Medicine Stem Cell Meeting on the Mesa, Oct-09-2015 04:20 PM
Oct 2 15
University of California-Los Angeles Presents at Alliance for Regenerative Medicine Stem Cell Meeting on the Mesa, Oct-09-2015 04:20 PM. Venue: Estancia La Jolla Hotel & Spa, 9700 North Torrey Pines Road, La Jolla, CA 92037, United States. Speakers: Donald Kohn, Professor, Department of Microbiology, Immunology & Molecular Genetics (MIMG) & Department of Pediatrics.
OncoSec Medical Inc. Collaborates with PerkinElmer, Inc. and the University of California, Los Angeles to Evaluate Patient-Selection Biomarker in Immunotherapy
Dec 2 14
OncoSec Medical Inc. announced a collaboration with PerkinElmer Inc. and the University of California, Los Angeles to help researchers develop biomarker tests to evaluate a patient's immune response to cancer. This research supports the ongoing shift in oncology toward therapeutic strategies that stimulate the patient's own immune defense system to combat cancer. The approach uses PerkinElmer's new imaging-based staining methods to quantitatively evaluate CD8+ T cell density in tumor biopsies.
FIbrocell Science Signs Exclusive Technology Licensing Pact with University of California-Los Angeles
Jun 28 14
Fibrocell Science announced that it has entered into an exclusive license agreement with The Regents of the University of California. Under the agreement, Fibrocell acquired the rights to commercially apply patented discoveries and technologies resulting from the ongoing scientific collaboration between the University of California at Los Angeles (UCLA) and Fibrocell Science. The technologies from the UCLA collaboration and exclusive license agreements enable Fibrocell to expand its proprietary Personalized Biologics platform which uses human fibroblasts and stem cells from skin to create localized therapies that are compatible with the biology of each patient. The license agreements build upon an existing research collaboration between Fibrocell and UCLA that has already yielded discoveries and technologies related to stem cells and regenerative cells in human skin.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|